Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study

Cheng, HY; Zhang, Z; Zhang, B; Zhang, W; Wang, J; Ni, WY; Miao, YW; Liu, JN; Bi, Y

Bi, Y (通讯作者),Nanjing Med Univ, Dept Endocrinol, Nanjing Drum Tower Hosp, Clin Coll,Branch Natl Clin Res Ctr Metab Dis, Nanjing, Peoples R China.;Bi, Y (通讯作者),Nanjing Univ, Sch Med, Dept Endocrinol, Nanjing Drum Tower Hosp,Affiliated Hosp, Nanjing, Peoples R China.

DIABETES CARE, 2022; 45 (5): 1201

Abstract

OBJECTIVE The comparative neuroprotective effects of different antidiabetes drugs have not been characterized in randomized controlled trials. Here, w......

Full Text Link